Form 4: International Isotopes Inc. Director Grosso Granted Stock Options
SEC Form 4 Filing
Director Christopher G. Grosso receives stock options for 1,500,000 shares of International Isotopes Inc.
Summary
- Christopher G. Grosso, a director of International Isotopes Inc. (INIS), was granted stock options on October 30, 2024.
- The options are for 1,500,000 shares of common stock.
- The exercise price of the options is $0.035 per share.
- The options expire on October 30, 2034.
- The options vest in three tranches: 33% on the grant date, 33% on the first anniversary, and 33% on the second anniversary of the grant date.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard executive compensation practice. The grant itself doesn't indicate positive or negative performance, but rather an incentive mechanism.
Positives
- The granting of stock options to a director can be seen as a positive sign, aligning the director's interests with those of the shareholders.
Industry Context
Stock options are a common form of executive compensation in the biotechnology and pharmaceutical industries, often used to incentivize performance and align management interests with shareholder value.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages across various industries, including those comparable to International Isotopes Inc.
- Companies like Nordion (Canada) Inc. and Advanced Accelerator Applications S.A. (France) also utilize stock options as part of their compensation strategy to attract and retain key personnel.
- The vesting schedule and exercise price are typical for such grants, aligning with industry norms for incentivizing long-term performance.
Stakeholder Impact
- The stock option grant could potentially impact shareholders by diluting equity if the options are exercised.
- It incentivizes the director to work towards increasing shareholder value.
Key Dates
| Date | Description |
|---|---|
| 10/30/2024 | Date of the stock option grant and initial transaction. |
| 10/30/2034 | Expiration date of the stock options. |
| 04/30/2025 | Date of signature by Attorney-in-fact. |
Keywords
stock options, director, INIS, International Isotopes Inc., beneficial ownership, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.